425
Views
31
CrossRef citations to date
0
Altmetric
Original Research

High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India

, &
Pages 57-61 | Published online: 30 Nov 2008

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosocomial and community pathogen. The objectives of this study were to estimate the prevalence of multidrug-resistant MRSA strains in clinical specimens and to investigate the sensitivity pattern of these strains against various antibiotics used for treating hospitalized and out patients. Strains were identified using standard procedures, and their sensitivity pattern was investigated using such techniques as disc diffusion, minimum inhibitory concentration (MIC), and the mecA gene PCR. Among 783 isolates of S. aureus, 301 (38.44%) were methicillin-resistant, of which 217 (72.1%) were found to be multidrug-resistant. Almost all MRSA strains were resistant to penicillin, 95.68% were resistant to cotrimoxazole, 92.36% were resistant to chloramphenicol, 90.7% were resistant to norfloxacin, 76.1% were resistant to tetracycline, and 75.75% were resistant to ciprofloxacin. Vancomycin was the most effective drug, with only 0.33% of MRSA strains being resistant to it. It is concluded that antibiotics other than vancomycin can be used as anti-MRSA agents after a sensitivity test so as to preclude the emergence of resistance to it and that prevailing problems in chemotherapy will escalate unless indiscriminate and irrational usage of antibiotics is checked.

Introduction

Infections caused by Staphylococcus aureus have a poorer prognosis when the infecting strain is MRSA (CitationCosgrove et al 2003). Since its first report in 1961 (CitationJevons 1961), the strain has been progressively causing increased mortality, morbidity, and health care costs with skin and soft tissue infections, ventilator-associated pneumonia, catheter associated bacteremia, and many other infections in hospitals and communities. First detected in hospitals, methicillin resistance is now increasingly recognized in the community (CitationChambers 2001).

In addition to dire consequences of infections, MRSA strains are important for their resistance to many other commonly used antibiotics and the emergence of resistance to vancomycin, the drug that has been used to treat MRSA infections for more than three decades. Thus, it is immensely important to study the antibiogram of MRSA in a given hospital so that the results of such studies can be exploited to minimize the irrational use of vancomycin when other antibiotics would cure an infection. Reports of emergence of vancomycin resistance in S. aureus from India (CitationAssadullah et al 2003; CitationTiwari and Sen 2006; CitationSaha et al 2008) further justify this necessity.

The prevalence of MRSA has varied from hospital to hospital in various countries. About 40% of S. aureus infections acquired in large US hospitals (500 or more beds) are methicillin-resistant (CitationRed Book 2003). Prevalence is constantly soaring in many countries, and in some hospitals, more than half of all S. aureus disease isolates are MRSA (CitationVoss and Doebbeling 1995). In many American and European hospitals, the percentage of MRSA has ranged from 29% to 35% of all clinical isolates. Meanwhile, information from developing countries is provided only by relatively sophisticated hospitals (Degerli et al 2000; Gastmeier et al 2000; CitationSantos et al 2000); as a consequence, the data on MRSA prevalence, most of which are from developed countries, are inadequate in estimating the overall global distribution (CitationPulimood et al 1996; CitationVerma et al 2000; CitationMajumder et al 2001; CitationTahnkiwale et al 2002; CitationAnupurba et al 2003; CitationMohanty et al 2004; CitationRajaduraipandi et al 2006; CitationMehta et al 2007; CitationMulla et al 2007).

The present study uncovers the prevalence of multidrug-resistant MRSA strains and investigates their antibiotic sensitivity pattern in a tertiary care hospital of northern India.

Material and methods

During August 2002 and June 2006, a total of 783 strains of S. aureus were isolated from various specimens of different patients visiting and admitted at Sir Sundar Lal Hospital, a 972 bed tertiary care teaching hospital of Banaras Hindu University at Varanasi, India.

Isolation and identification of staphylococci from clinical specimens

All specimens, except urine for which cystine lactose electrolyte deficient agar (HiMedia, New Delhi, India) was used, were cultured on blood agar and MacConkey agar (HiMedia, New Delhi, India). S. aureus was identified and differentiated from related organisms on the basis of colony morphology, Gram staining, catalase test, tube coagulase test using rabbit plasma, slidex staph plus (Biomerurix India Ltd, New Delhi, India), thermonuclease and acetoin production, and mannitol fermentation (CitationBarid 1996). Using growth on blood agar, all the strains were subjected to the following tests. S. aureus ATCC 25923 (mecA negative) and ATCC 43300 (mecA positive) were used for the quality control of all the tests.

Disc diffusion test by Kirby–Bauer method

Mueller–Hinton agar (MHA) plates were overlaid with the saline suspension of a strain (turbidity matching 0.5 McFarland standard), and the following antibiotic discs procured from HiMedia, India were placed on the plate after 10 minutes, with six discs on a plate: penicillin (10 U), oxacillin (1 μg), gentamicin (10 μg), tobramycin (30 μg), amikacin (30 μg), netilmicin (30 μg), norfloxacin (10 μg), ciprofloxacin (5 μg), chloramphenicol (30 μg), erythromycin (15 μg), tetracycline (15 μg), trimethoprim/sulfamethoxazole (1.25/23.75 μg), nitrofurantoin (300 μg), vancomycin (30 μg), and sulbactam/cefoperazone (30/75 μg). After 24 and 48 h of incubation at 35 °C, the plates were read using the NCCLS break-points as reference (CitationNCCLS 2004).

Oxacillin MIC test

Gradient plates of MHA containing 2% NaCl were prepared with doubling dilutions (from 0.25 μg/ml to 256 μg/ml) of oxacillin. Inoculum was prepared by diluting 0.5 McFarland equivalent suspension of a strain with sterile normal saline to the concentration of 104 CFU/ml. The plates were spot-inoculated and incubated at 35 °C for 24 h. An oxacillin minimum inhibitory concentration (MIC) of ≤2 μg/ml indicated that the strain was susceptible and that of >2 μg/ml resistant (CitationNCCLS 2003).

The mecA gene detection by PCR

Staphylococcal DNA was isolated using chloroform: phenol extraction method (CitationSambrook et al 1989). The primers used for detection of the mecA gene were MecA1 (5’-GTA GAA ATG ACT GAA CGT CCG ATA A) and MecA2 (5’-CCA ATT CCA CAT TGT TTC GGT CTA A), as described earlier (CitationGeha et al 1994). A Biometra DNA thermocycler was programmed for initial denaturation at 94 °C for 4 min; 30 cycles of amplification (denaturation at 94 °C for 45 sec, annealing at 56 °C for 45 sec, and extension at 72 °C for 30 sec); and a final extension at 72 °C for 2 min. To visualize, 10 μl of the PCR amplicon was loaded in 2% agarose gel in TBE (0.089 M Tris, 0.089 M boric acid, 0.002 M EDTA) containing 0.5 μl/ml of ethidium bromide and visualized by using UV transillumination at 300 nm. DNA fragments of 310 bp corresponded to the mecA gene.

Results

Of the 783 S. aureus strains (503 from outpatient departments [OPDs] and 280 from wards), 301 (38.44%) – 187 from OPDs and 114 from wards – showed methicillin resistance in disc diffusion and MIC tests and were confirmed as MRSA by the mecA gene PCR. The remaining 482 (61.56%) were MSSA. shows the pattern of resistance shown by MRSA strains as well as compares its distribution in OPDs and wards. Resistance to penicillin was highest (97%) followed by cotrimoxazole (95.68%), chloramphenicol (92.36%), and norfloxacin (90.7%).

Table 1 Resistance pattern of MRSA against various antimicrobials and its relative distribution in OPDs and wards

The resistance pattern of MRSA was somewhat varying between OPDs and wards for macrolides, chloramphenicol, tetracycline, cotrimoxazole, nitrofurantoin and betalactam/betalactamase inhibitor combination; the pattern was more or less same for other antibiotics ().

Out of 301 MRSA isolates, 217 (72.1%) were multidrug resistant, with 136 being resistant to more than three antimicrobials except vancomycin. One MRSA strain was found to be resistant to all antibiotics including vancomycin ().

Table 2 Multidrug resistanceTable Footnote* in MRSA

Frequency of isolating MRSA was maximum in cutaneous and wound specimens (42.2%) followed by blood, respiratory specimens, and urine ().

Table 3 Frequency of S. aureus and MRSA in specimens

Discussion

Studies show that the epidemiology of MRSA over different parts of India is not uniform. The present study reports 38.44% MRSA among S. aureus isolates, whereas an earlier study done in the same hospital here had shown a higher prevalence of 54.8% (CitationAnupurba et al 2003). Some studies have reported comparable prevalence: 38.56% in Delhi (CitationMohanty et al 2004), 31.1% in a multicenter study in Tamilnadu (CitationRajaduraipandi et al 2006), and 39.50% in South Gujarat (CitationMulla et al 2007). In contrast, other studies have reported entirely different prevalence: 24% in Vellore (CitationPulimood et al 1996), 80.89% in Indore (CitationVerma et al 2000), 52.9% in Assam (CitationAssadullah et al 2003), 19.56% in Nagpur (CitationTahnkiwale et al 2002), and 24% in Chandhigarh (CitationMehta et al 2007). Although it’s extremely difficult to explain these conflicting data with regards to both time and place of study, the variation is probably due to differential clonal expansion and drug pressure in community.

Given the fact that staphylococci spread by direct or indirect person-to-person contact, the emergence of multidrug-resistant stains of MRSA is worrisome in the present therapeutic scenario. Multidrug resistance was defined as resistance of a MRSA strain towards three or more antibiotics at a given point of time. In the USA, some workers (CitationStyers et al 2006) have reported multi-drug resistance rates of 67.8% (for inpatients) and 65% (for outpatients) in lower respiratory tract MRSA isolates. In Nigerian women, a total of 43 S. aureus out of 60 were found to be multidrug resistant (CitationOnanuga et al 2005). We found a high percentage of multidrug-resistant MRSA (72.1%) in our hospital. If we look into the Indian literature, it seems the burden of multi drugresistant-MRSA is increasing over time: for instance, 23.2% was reported by CitationMajumder and colleagues in 2001; 32% by Anupurva and colleagues in 2003; and 63.6% by CitationRajaduraipandi and colleagues 2006. The lesson is clear: MRSA surveillance and strict drug policy are of paramount importance, or else the threat will increase.

The MRSA strain that showed resistance to all antimicrobials including vancomycin was isolated from a 56-year-old male patient admitted in post-operative ward of our hospital. The zone of inhibition shown by this strain in response to vancomycin disc was less than 9 mm; therefore we tentatively characterized this strain as vancomycin resistant S. aureus. Molecular investigation of the strain for the presence of vanA/B gene is needed to clarify its exact status.

Patterns of resistance shown by MRSA to Beta-lactams, aminoglycosides and quinolones are more or less identical in OPDs and wards, while the same to erythromycin, chloramphenicol, tetracycline, cotrimoxazole, nitrofurantoin, and betalactam/betalactamase inhibitor combination present certain level of difference between their distributions in OPDs and wards. This is a reflection of differential drug pressure.

Currently, the majority (80%–90%) of S. aureus strains in communities are beta-lactamase producers hence resistant to penicillin and ampicillin (CitationParadisi et al 2001; CitationAng 2004). Recently more than 90% isolates from South Maharashtra have been found resistant to ampicillin, tobramycin, penicillin, erythromycin, kanamycin and gentamicin, whereas only 39.1% of strains are resistant to methicillin (CitationKandle et al 2003). The choice is obviously oxacillin; however, fearing MRSA, clinicians may exploit vancomycin. Our study reports that antibiotics other than vancomycin – for instance, amikacin, tobramycin, gentamicin, cefoperazone/sulbactam – can be promising if a susceptibility testing is done, reserving vancomycin for life-threatening infections. A retrospective study of bacterial isolates from cases of neonatal septicemia over a period of five years from Chandigarh, India, has also reported that netilmicin was the most effective drug for S. aureus (CitationAgnihotri et al 2004).

Factors contributing to drug resistance in developing countries are myriad. Antibiotics are available without prescription at drug stores or even at general stores and injudiciously used in communities, animal husbandries, and fisheries. Traditional practitioners use allopathic drugs, and many practitioners who earn by selling medicines prescribe more drugs than necessary (CitationHolloway 2000). In a study from five districts of Tamilnadu, India, 285 general practitioners and specialists believed that antibiotics are over-prescribed: purulent discharge (65%), antibiotic-resistance concerns (48%), fever (40%), and patient satisfaction (29%) being the strong reasons for overprescription (CitationSivagnanam et al 2004). Poor quality antibiotics are produced at local levels, and patients show poor compliance to costly antimicrobials (CitationHart 1998). Therefore, there is no other way than to foil these malpractices, to constantly conduct microbiological surveillance like this, and follow infection control measures like hand washing and other aseptic techniques if we are to avoid therapeutic crisis resulting from multidrug-resistant MRSA.

Acknowledgements

Hare Krishna Tiwari is thankful to the University Grant Commission, Kathmandu, Nepal for providing partial fellowship for this work. The authors report no conflicts of interest in this work.

References

  • AgnihotriNKaisthaNGuptaV2004Antimicrobial susceptibility of isolates from neonatal septicemiaJpn J Infect Dis572737515623955
  • AngJYEzikeEAsmarBI2004Antibacterial resistanceIndian J Pediatr712293915080410
  • AnupurbaSSenMRNathG2003Prevalence of methicillin resistant Staphylococcus aureus in a Tertiary care Referral Hospital in Eastern UttarPradeshIndian J Med Microbiol21495117642975
  • AssadullahSKakruDKThokerMA2003Emergence of low level vancomycin resistance in MRSAIndian J Med Microbiol21196817643019
  • BaridD1996Staphylococcus: Cluster–forming Gram–positive cocci, Chapter 11ColleeJGFraserAGMarmionBPMackie and McCartney Practical Medical Microbiology14th edNew YorkChurchill Livingstone
  • ChambersHF2001The changing epidemiology of Staphylococcus aureusEmerg Infect Dis71788211294701
  • CosgroveSESakoulasGPerencevichEN2003Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysisClin Infect Dis3653912491202
  • DeğerliKÖzbakkaloğluBSürücüoğluS2000The susceptibility rates of Staphylococcus aureus strains to various antibiotics isolated from clinical specimensInfek Derg148790
  • GastmeierPSohrDGeffersC2002Occurrence of methicillin resistant Staphylococcus aureus infections in German intensive care unitsInfection3019820212236560
  • GehaDJUhlJRGustaferroCA1994Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratoryJ Clin Microbiol321768727929772
  • HartCAKariukiS1998Antimicrobial resistance in developing countriesBMJ317647509727995
  • HollowayK2000Antimicrobial resistance: the factsEssential Drug Monitor WHO28&2978
  • JevonsMP1961“Celbenin”-resistant staphylococciBr Med J112425
  • KandleSKGhatoleMPTakpereAY2003Bacteriophage typing and antibiotic sensitivity pattern of Staphylococcus aureus from clinical specimen in and around Solapur (South Maharashtra)J Commun Dis35172315239300
  • MajumderDBordoloiJNPhukanAC2001Antimicrobial susceptibility pattern among methicillin resistant Staphylococcus isolates in AssamIndian J Med Microbiol191384017664816
  • MehtaMDuttaPGuptaV2007Bacterial isolates from burn wound infections and their antibiograms: A eight-year studyIndian J Plast Surg40258
  • MohantySKapilADhawanB2004Bacteriological and antimicrobial susceptibility profile of soft tissue infections from Northern IndiaIndian J Med Microbiol581015
  • MullaSPatelMShahL2007Study of antibiotic sensitivity pattern of methicillin-resistant Staphylococcus aureusIndian J Crit Care Med1199101
  • [NCCLS] National Committee for Clinical Laboratory Standards2003Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard M7-A6NCCLSWayne, PA, USA
  • [NCCLS] National Committee for Clinical Laboratory Standards2004Performance standards for antimicrobial disc susceptibility testing: Fourteenth Informational Supplement M100-S14NCCLSWayne, PA, USA
  • OnanugaAOyiAROlayinkaBO2005Prevalence of community-associated multi-resistant Staphylococcus aureus among healthy women in Abuja, NigeriaAfrican J Biotech494245
  • ParadisiFCortiGMesseriD2001Antibiotic therapy. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibioticsMed Clin North Am8511711190346
  • PulimoodTBLalithaMKJesudasonMV1996The spectrum of antimicrobial resistance amongst MRSA in a tertiary care centre in IndiaInd J Med Res1032125
  • RajaduraipandiKManiKRPanneerselvamK2006Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: A multicentre studyInd J Med Microbiol24348
  • Red Book2003Report of the Committee on Infectious Diseases26th edStaphylococcal Infections56173
  • SahaBSinghAKGhoshA2008Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia)J Med Microbial57729
  • SambrookJFritschEFManiatisT1989Molecular Cloning: a Laboratory Manual2nd edNew YorkCold Spring Harbor Laboratory Press
  • SantosSIMatoRde LencastreH2000CEM/NET Collaborators and the International Collaborators. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998Microb Drug Resist619921111144420
  • SivagnanamGThirumalaikolundusubramanianPMohanasundaramJ2004A survey on current attitude of practicing physicians upon usage of antimicrobial agents in southern part of IndiaMed Gen Med61
  • StyersDSheehanDJHoganP2006Laboratory-based surveillance of current antimicrobial patterns and trends among Staphylococcus aureus: 2005 status in the United StatesAnn Clinl Microbiol Antimicrobl52
  • TahnkiwaleSSRoySJalgaonkarSV2002Methicillins resistance among isolates of Staphylococcus aureus: antibiotic sensitivity pattern and phage typingInd J Med Sci563304
  • TiwariHKSenMR2006Emergence of VRSA from a tertiary care hospital from northern part of IndiaBMC Infect Dis615617067393
  • VermaSJoshiSChitnisV2000Growing problem of methicillin resistant staphylococci: Indian ScenarioIndian J Med Sci545354011354818
  • VossADoebbelingBN1995The worldwide prevalence of methicillin resistant Staphylococcus aureusInt J Antimicrob Agents5101618611655